Authors:
ESSERS AJA
ALINK GM
SPEIJERS GJA
ALEXANDER J
BOUWMEISTER PJ
VANDENBRANDT PA
CIERE S
GRY J
HERRMAN J
KUIPER HA
MORTBY E
RENWICK AG
SHRIMPTON DH
VAINIO H
VITTOZZI L
KOEMAN JH
Citation: Aja. Essers et al., FOOD PLANT TOXICANTS AND SAFETY - RISK ASSESSMENT AND REGULATION OF INHERENT TOXICANTS IN PLANT FOODS, Environmental toxicology and pharmacology, 5(3), 1998, pp. 155-172
Citation: Ag. Renwick et Nr. Lazarus, HUMAN VARIABILITY AND NONCANCER RISK ASSESSMENT - AN ANALYSIS OF THE DEFAULT UNCERTAINTY FACTOR, Regulatory toxicology and pharmacology, 27(1), 1998, pp. 3-20
Citation: J. Armstrong et al., THE INFLUENCE OF 2 TYPES OF MEAL ON THE PHARMACOKINETICS OF A MODIFIED-RELEASE FORMULATION OF NIFEDIPINE (ADALAT RETARD), European Journal of Clinical Pharmacology, 53(2), 1997, pp. 141-143
Citation: Ag. Renwick et D. Hattis, INTRODUCTION TO THE WORKSHOP ON VARIABILITY IN TOXIC RESPONSE - HUMANAND ENVIRONMENTAL - RAPPORTEURS SUMMARY, Environmental toxicology and pharmacology, 2(2-3), 1996, pp. 79-84
Authors:
SUMMERS QA
FLEMING JS
DAI Y
PERRING S
HONEYWELL R
GOUGH KJ
RENWICK AG
CLARK AR
NASSIM MA
HOLGATE ST
Citation: Qa. Summers et al., THE PULMONARY DEPOSITION OF 2 AEROSOL PREPARATIONS OF NEDOCROMIL SODIUM DELIVERED BY MDI ASSESSED BY SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY, Journal of aerosol medicine, 9, 1996, pp. 93-109
Authors:
ROBERTS J
WALLER DG
RENWICK AG
OSHEA N
MACKLIN BS
BULLING M
Citation: J. Roberts et al., THE EFFECTS OF COADMINISTRATION OF BENZHEXOL ON THE PERIPHERAL PHARMACOKINETICS OF ORAL LEVODOPA IN YOUNG VOLUNTEERS, British journal of clinical pharmacology, 41(4), 1996, pp. 331-337
Citation: B. Schilter et al., LIMITS FOR PESTICIDE-RESIDUES IN INFANT FOODS - A SAFETY-BASED PROPOSAL, Regulatory toxicology and pharmacology, 24(2), 1996, pp. 126-140
Citation: Ag. Renwick, NEEDS AND METHODS FOR PRIORITY SETTING FOR ESTIMATING THE INTAKE OF FOOD-ADDITIVES, Food additives and contaminants, 13(4), 1996, pp. 467-475
Citation: Ea. Tembe et al., ALL-TRANS-RETINOIC ACID IN MATERNAL PLASMA AND TERATOGENICITY IN RATSAND RABBITS, Toxicology and applied pharmacology, 141(2), 1996, pp. 456-472
Authors:
DOLL R
ROBERTS LEJ
COX R
STATHER JW
WARNER F
ADAMS GE
ROTBLAT J
CRUMPTON MJ
ARRAND JE
FIELDER R
FINNEY DJ
COGGON D
MCQUAID J
LEWINS JD
SUCKLING CW
ILLING HP
CHADWICK KH
LEENHOUTS HP
HRUDEY SE
LOVELL D
EDWARDS JH
WATSON WP
VANSITTERT NJ
HARBISON S
RENWICK AG
WOODS HF
KING N
BUTLER PJG
GILLIAT BS
CLAYTON DB
RIMINGTON JD
Citation: R. Doll et al., EXTRAPOLATION OF DOSE-RESPONSE DATA FOR RISK ASSESSMENT - DISCUSSION, Process safety and environmental protection, 73(B4), 1995, pp. 43-54
Authors:
SOWUNMI A
RASHID TJ
AKINYINKA OO
RENWICK AG
Citation: A. Sowunmi et al., ETHNIC-DIFFERENCES IN NIFEDIPINE KINETICS - COMPARISONS BETWEEN NIGERIANS, CAUCASIANS AND SOUTH ASIANS, British journal of clinical pharmacology, 40(5), 1995, pp. 489-493
Authors:
ROBERTS J
WALLER DG
OSHEA N
MACKLIN BS
RENWICK AG
Citation: J. Roberts et al., THE EFFECT OF SELEGILINE ON THE PERIPHERAL PHARMACOKINETICS OF LEVODOPA IN YOUNG VOLUNTEERS, British journal of clinical pharmacology, 40(4), 1995, pp. 404-406
Authors:
RASHID TJ
MARTIN U
CLARKE H
WALLER DG
RENWICK AG
GEORGE CF
Citation: Tj. Rashid et al., FACTORS AFFECTING THE ABSOLUTE BIOAVAILABILITY OF NIFEDIPINE, British journal of clinical pharmacology, 40(1), 1995, pp. 51-58
Citation: Ag. Renwick, THE USE OF AN ADDITIONAL SAFETY OR UNCERTAINTY FACTOR FOR NATURE OF TOXICITY IN THE ESTIMATION OF ACCEPTABLE DAILY INTAKE AND TOLERABLE DAILY INTAKE VALUES, Regulatory toxicology and pharmacology, 22(3), 1995, pp. 250-261
Citation: Sc. Lee et Ag. Renwick, SULFOXIDE REDUCTION BY RAT INTESTINAL FLORA AND BY ESCHERICHIA-COLI IN-VITRO, Biochemical pharmacology, 49(11), 1995, pp. 1567-1576
Authors:
BUSS NE
TEMBE EA
PRENDERGAST BD
RENWICK AG
GEORGE CF
Citation: Ne. Buss et al., THE TERATOGENIC METABOLITES OF VITAMIN-A IN WOMEN FOLLOWING SUPPLEMENTS AND LIVER, Human & experimental toxicology, 13(1), 1994, pp. 33-43
Authors:
RASHID J
MCKINSTRY C
RENWICK AG
DIRNHUBER M
WALLER DG
GEORGE CF
Citation: J. Rashid et al., QUERCETIN, AN IN-VITRO INHIBITOR OF CYP3A, DOES NOT CONTRIBUTE TO THEINTERACTION BETWEEN NIFEDIPINE AND GRAPEFRUIT JUICE, British journal of clinical pharmacology, 36(5), 1993, pp. 460-463
Citation: Ag. Renwick et R. Walker, AN ANALYSIS OF THE RISK OF EXCEEDING THE ACCEPTABLE OR TOLERABLE DAILY INTAKE, Regulatory toxicology and pharmacology, 18(3), 1993, pp. 463-480
Citation: Ag. Renwick, DATA-DERIVED SAFETY FACTORS FOR THE EVALUATION OF FOOD-ADDITIVES AND ENVIRONMENTAL CONTAMINANTS, Food additives and contaminants, 10(3), 1993, pp. 275-305
Citation: Ag. Renwick, A DATA-DERIVED SAFETY (UNCERTAINTY) FACTOR FOR THE INTENSE SWEETENER,SACCHARIN, Food additives and contaminants, 10(3), 1993, pp. 337-350